xaliproden has been researched along with pentoxifylline in 1 studies
Studies (xaliproden) | Trials (xaliproden) | Recent Studies (post-2010) (xaliproden) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
---|---|---|---|---|---|
41 | 2 | 9 | 4,437 | 657 | 943 |
Protein | Taxonomy | xaliproden (IC50) | pentoxifylline (IC50) |
---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | 6.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abitbol, JL; Corcia, P; Cudkowicz, M; Gordon, PH; Lacomblez, L; Leigh, PN; Meininger, V; Pochigaeva, K | 1 |
1 review(s) available for xaliproden and pentoxifylline
Article | Year |
---|---|
Defining survival as an outcome measure in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Endpoint Determination; Humans; Kaplan-Meier Estimate; Naphthalenes; Outcome Assessment, Health Care; Pentoxifylline; Pyridines; Respiration, Artificial; Respiratory Paralysis; Tracheostomy; Vasodilator Agents | 2009 |